Merck KGaA to buy gene therapy tools maker for $600M

Merck KGaA to buy gene therapy tools maker for $600M

Submitted by admin on May 23, 2024 - 9:37pm
Source: 
BioPharma Dive
News Tags: 
Merck KGaA
M&A
MilliporeSigma
Gamma Biosciences
gene therapy
Headline: 
Merck KGaA to buy gene therapy tools maker for $600M
snippet: 

The German drugmaker is bolstering its MilliporeSigma business with a unit of Gamma Biosciences that specializes in so-called transfection reagents.

Do Not Allow Advertisers to Use My Personal information